Contemporary results of surgical resection of non-small cell lung cancer after induction therapy: A review of 549 consecutive cases

Journal of Thoracic Oncology

Volumn 6, Issue 9, 2011, Pages 1530-1536

  Barnett, Stephen A ^a,b   Rusch, Valerie W ^a   Zheng, Junting ^a   Park, Bernard J ^a,c   Rizk, Nabil P ^a   Plourde, Gabriel ^a   Bains, Manjit S ^a   Downey, Robert J ^a   Shen, Ronglai ^a   Kris, Mark G ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Harold Stokes Building ^*  (Australia)

^c HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Induction therapy; Lung cancer; Neoadjuvant therapy; Surgical morbidity and mortality

Indexed keywords

CISPLATIN DERIVATIVE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INDUCTION CHEMOTHERAPY; CANCER RADIOTHERAPY; FEMALE; HUMAN; LOBECTOMY; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; PRIORITY JOURNAL; SURGICAL MORTALITY; SURGICAL RISK;

EID: 80052272870     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e318228a0d8     Document Type: Article

References (43)

1. Goldstraw P, Crowley J, Chansky K, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007;2:706-714. (Pubitemid 47357522)
2. Rusch VW, Crowley J, Giroux DJ, et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2007;2:603-612. (Pubitemid 47171781)
3. Arriagada R, Bergman B, Dunant A, et al. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell lung cancer. N Engl J Med 2004;350:351-360. (Pubitemid 38101630)
4. Pignon J-P, Burdett S. Comment on "Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature" by T. Berghmans, M. Paesmans, A.P. Meert, C. Mascaus, P. Lothaire, J.J. Lafitte, et al. [Lung Cancer 49 (2005) 13-23]. Lung Cancer 2006;51:261-262.
5. Winton T, Livingston R, Johnson D, et al. Vinorelbine plus cisplatin vs. observation in resected non-small cell lung cancer. N Engl J Med 2005;352:2589-2597. (Pubitemid 41007845)
6. Douillard J-Y, Rosell R, De Lena M, et al. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol 2006;7:719-727. (Pubitemid 44283661)
7. Stewart LA, Burdett S, Tierney JF, et al; The NSCLC Collaborative Group. Surgery and adjuvant chemotherapy (CT) compared to surgery alone in non-small cell lung cancer (NSCLC): A meta-analysis using individual patient date (IPD) from randomized clinical trials (RCT). J Clin Oncol 2007;25(18S):7552 (abstract).
8. Alam N, Shepherd FA, Winton T, et al. Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer. An analysis of National Cancer Institute of Canada and intergroup trial JBR. 10 and a review of the literature. Lung Cancer 2005;47:385-394. (Pubitemid 40248743)
9. Van Meerbeeck JP, Kramer GW, Van Schill PE, et al. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small cell lung cancer. J Nat Cancer Inst 2007;99:442-450. (Pubitemid 47073567)
10. Pisters KM, Ginsberg RJ, Giroux DJ, et al. Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. J Thorac Cardiovasc Surg 2000;119:429-439. (Pubitemid 30146520)
11. Doddoli C, Barlesi F, Trousse D, et al. One hundred consecutive pneumonectomies after induction therapy for non-small cell lung cancer: An uncertain balance between risks and benefits. J Thorac Cardiovasc Surg 2005;130:416-425. (Pubitemid 41074173)
12. Martin J, Ginsberg RJ, Abolhoda A, et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: The risks of right pneumonectomy. Ann Thorac Surg 2001;72:1149-1154. (Pubitemid 32937994)
13. Albain KS, Swann RS, Rusch VW, et al. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small cell lung cancer: A phase III randomised controlled trial. Lancet 2009;374:379-386.
14. Weder W, Collaud S, Eberhardt WE, et al. Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small cell lung cancer. J Thorac Cardiovasc Surg 2010;139:1424-1430.
15. Pierce RJ, Copland JM, Sharpe K, et al. Preoperative risk evaluation for lung cancer resection: Predicted postoperative product as a predictor of surgical mortality. Am J Respir Crit Care Med 1994; 150:947-955. (Pubitemid 24318018)
16. Cooper JD, Nelems JM, Pearson FG. Extended indications for median sternotomy in patients requiring pulmonary resection. Ann Thorac Surg 1978;26:413-420. (Pubitemid 9060644)
17. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3:32-35.
18. Allen MS, Darling GE, Pechet TT, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: Initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg 2006;81:1013-1020. (Pubitemid 43247678)
19. Fang D, Zhang D, Huang G, et al. Results of surgical resection of patients with primary lung cancer: A retrospective analysis of 1,905 cases. Ann Thorac Surg 2001;72:1155-1159. (Pubitemid 32937996)
20. Duque JL, Ramos G, Castrodeza J, et al. Early complications in surgical treatment of lung cancer: A prospective, multicenter study. Ann Thorac Surg 1997;63:944-950. (Pubitemid 27191641)
21. Sonett JR, Suntharalingam M, Edelman MJ, et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Ann Thorac Surg 2004;78:1200-1206.
22. Cerfolio RJ, Bryant AS, Spencer SA, et al. Pulmonary resection after high-dose and low-dose chest irradiation. Ann Thorac Surg 2005;80: 1224-1230. (Pubitemid 41354093)
23. Roth JA, Fossella F, Komaki R, et al. A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. J Nat Cancer Inst 1994;86:673-680.
24. Depierre A, Milleron B, Moro-Sibilot D, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small cell lung cancer. J Clin Oncol 2001;20:247-253.
25. Van Schil P, van Meerbeeck J, Kramer G, et al. Morbidity and mortality in the surgery arm of EORTC 08941 trial. Eur Respir J 2005;26:1-6.
26. Watanabe S-I, Asamura H, Suzuki K, et al. Recent results of postoperative mortality for surgical resections in lung cancer. Ann Thorac Surg 2004;78:999-1003.
27. Rami-Porta R, Mateu-Navarro M, Freixinet J, et al. Type of resection and prognosis in lung cancer. Experience of a multicentre study. Eur J Cardiothorac Surg 2005;28:622-628. (Pubitemid 41348690)
28. Gilligan D, Nicolson M, Smith I, et al. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: Results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review. Lancet 2007;369:1929-1937. (Pubitemid 46874559)
29. Daly BD, Fernando HC, Ketchedjian A, et al. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. Ann Thorac Surg 2006;82:227-231.
30. Gudbjartsson T, Gyllstedt E, Pikwer A, et al. Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy. Ann Thorac Surg 2008; 86:376-382. (Pubitemid 351978030)
31. Roberts JR, Eustis C, Devore R, et al. Induction chemotherapy increases perioperative complications in patients undergoing resection for nonsmall cell lung cancer. Ann Thorac Surg 2001;72:885-888. (Pubitemid 32846252)
32. Stamatis G, Djuric D, Eberhardt W, et al. Postoperative morbidity and mortality after induction chemoradiotherapy for locally advanced lung cancer: Analysis of 350 operated patients. Eur J Cardiothorac Surg 2002;22:292-297. (Pubitemid 34831873)
33. Matsubara Y, Takeda S-I, Mashimo T. Risk stratification for lung cancer surgery. Impact of induction therapy and extended resection. Chest 2005;128:3519-3525. (Pubitemid 41698687)
34. Perrot E, Guibert B, Mulsant P, et al. Preoperative chemotherapy does not increase complications after nonsmall cell lung cancer resection. Ann Thorac Surg 2005;80:423-427. (Pubitemid 41019453)
35. Mansour Z, Kochetkova EA, Ducrocq X, et al. Induction chemotherapy does not increase the operative risk of pneumonectomy! Eur J Cardiothorac Surg 2007;31:181-185. (Pubitemid 46150064)
36. Olsen GN, Block AJ, Swenson EW, et al. Pulmonary function evaluation of the lung resection candidate: A prospective study. Am Rev Respir Dis 1975;111:379-387.
37. Barrera R, Shi W, Amar D, et al. Smoking and timing of cessation. Impact on pulmonary complications after thoracotomy. Chest 2005;127: 1977-1983.
38. Ferguson MK, Little L, Rizzo L, et al. Diffusing capacity predicts morbidity and mortality after pulmonary resection. J Thorac Cardiovasc Surg 1988;96:894-900. (Pubitemid 19007856)
39. Colice GL, Shafazand S, Griffin JP, et al; The American College of Chest Physicians. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidencebased clinical practice guidelines (2nd edition). Chest 2007; 132(Suppl 3):161S-177S. (Pubitemid 47502806)
40. Grigoriu B-D, Scherpereel A, Devos P, et al. Utility of osteopontin and serum mesothelin in malignant pleural mesothelioma diagnosis and prognosis assessment. Clin Cancer Res 2007;13:2928-2935. (Pubitemid 46850705)
41. Ferguson MK, Reeder LB, Mick R. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg 1995;109:275-283.
42. Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis 1989;139:902-910. (Pubitemid 19094312)
43. Ferguson MK, Durkin AE. A comparison of three scoring systems for predicting complications after major lung resection. Eur J Cardiothorac Surg 2003;23:35-42. (Pubitemid 35472094)